Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT05111054
Other study ID # 290580-LOAD
Secondary ID
Status Suspended
Phase N/A
First received
Last updated
Start date January 2023
Est. completion date January 2024

Study information

Verified date November 2021
Source Durham University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Purpose: To investigate the impact of exercise load on resistance exercise-induced muscle damage in untrained males and females. Rationale: Unaccustomed resistance exercise can cause muscle damage, presenting as muscle soreness and reduced muscle function - such as loss of strength, power, and flexibility - for several days after the exercise bout. Therefore, individuals may require longer recovery periods before performing another exercise bout, and their performance may be impaired. Further, muscle soreness may reduce exercise compliance, particularly in novice individuals. Over time, this may compromise the gains in muscle mass and strength achieved through exercise training. Therefore, strategies to reduce the severity of exercise-induced muscle damage and/or to enhance post-exercise recovery processes are advantageous for exercising individuals. One such strategy is to perform resistance exercise with lighter loads, i.e. <70% one repetition maximum (1RM). Low-load resistance training has shown to induce comparable gains in muscle mass and strength to high-load (≥70% 1RM), while being perceptively less exerting. Low-load resistance exercise may place less mechanical stress on muscle fibres and accordingly, its impact on muscle damage has been investigated. While several studies have reported less severe muscle damage, muscle soreness, and functional impairments with low-load resistance exercise compared to high-load, others have found no differences. Further, there is a lack of studies conducted solely in females or comparing between sexes. It has been suggested that males and females respond differently to muscle damage, and therefore, this research aims to provide a sex comparison in the muscle damage response to an acute bout of resistance exercise performed with low or high loads. Therefore, 40 healthy, young (18-35 years) adults (20 males, 20 females) will be recruited to participate in this randomised controlled trial. Maximal leg strength and body composition (by dual-energy X-ray absorptiometry; DXA) will be conducted at baseline. In females, all primary outcome measures will be obtained during the late follicular phase of the menstrual cycle. Participants will then be randomised to a low-load (30% 1RM) or high-load (80% 1RM) exercise condition. Three weeks later, participants will complete a resistance exercise session at their allocated intensity on leg extension and leg curl machines to induce muscle damage. Various measures of muscle damage (blood biomarkers, muscle soreness, flexibility, and swelling) will be obtained before, immediately after, and 24, 48, 72, and 168 h after the exercise protocol. The maximal strength test will be repeated 72 and 168 h after the exercise. Participants' habitual activity and dietary intake will be monitored and controlled throughout the study period. Expected outcome: It is expected that the resistance exercise protocol will induce muscle damage, which will be less severe in the low-load exercise condition. It cannot be ascertained whether males and females will have the same responses to the exercise.


Recruitment information / eligibility

Status Suspended
Enrollment 40
Est. completion date January 2024
Est. primary completion date January 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - BMI 18.5 - 25.0 kg/m2 - Untrained in resistance exercise - No known chronic disease or current acute illness - No current or recent (past 3 months) musculoskeletal injury - No frequent use (2x per week for past month) of non-steroidal anti-inflammatory drugs, anti-oxidant supplements, polyunsaturated omega-3 fatty acids (and other substances that may alleviate muscle damage) and compliant to abstain from use during experimental period - No recent or current engagement in massage or cryotherapy and compliant to abstain from use during experimental period - Females will be eumenorrheic (regular menstrual cycle) >12 months - Absence of pregnancy and breast-feeding Exclusion Criteria: - Underweight - Overweight/obese - Resistance trained - Current or recent injury - Pregnancy or breast-feeding - Unwilling to provide blood samples, perform resistance exercise, or abstain from use of NSAID's and other substances (stated above) - Unwilling to abstain from other forms of exercise during the experimental period

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Resistance Exercise
Acute leg-based resistance exercise bout (3 sets performed to volitional failure on leg extension and leg curl machines)

Locations

Country Name City State
United Kingdom Durham University, The Graham Sports Centre Durham County Durham

Sponsors (1)

Lead Sponsor Collaborator
Durham University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maximal Voluntary Contraction at baseline One-repetition maximum (1RM) test: leg extension and leg curl machines Baseline
Primary Change from baseline Maximal Voluntary Contraction at 72-hours post-exercise One-repetition maximum (1RM) test: leg extension and leg curl machines 72-hours after the exercise bout
Primary Change from baseline Maximal Voluntary Contraction at 168-hours post-exercise One-repetition maximum (1RM) test: leg extension and leg curl machines 168-hours after the exercise bout
Primary Creatine kinase concentration at baseline Serum concentration of creatine kinase from venous blood sampling Immediately pre-exercise
Primary Change from baseline in Creatine Kinase concentration immediately post-exercise Serum concentration of creatine kinase from venous blood sampling Immediately after the exercise bout
Primary Change from baseline in Creatine Kinase concentration at 24-hours post-exercise Serum concentration of creatine kinase from venous blood sampling 24-hours after the exercise bout
Primary Change from baseline in Creatine Kinase concentration at 48-hours post-exercise Serum concentration of creatine kinase from venous blood sampling 48-hours after the exercise bout
Primary Change from baseline in Creatine Kinase concentration at 72-hours post-exercise Serum concentration of creatine kinase from venous blood sampling 72-hours after the exercise bout
Primary Change from baseline in Creatine Kinase concentration at 168-hours post-exercise Serum concentration of creatine kinase from venous blood sampling 168-hours after the exercise bout
Primary Interleukin-6 concentration at baseline Serum concentration of Interleukin-6 from venous blood sampling Immediately pre-exercise
Primary Change from baseline in Interleukin-6 concentration immediately post-exercise Serum concentration of Interleukin-6 from venous blood sampling Immediately after the exercise bout
Primary Change from baseline in Interleukin-6 concentration at 24-hours post-exercise Serum concentration of Interleukin-6 from venous blood sampling 24-hours after the exercise bout
Primary Change from baseline in Interleukin-6 concentration at 48-hours post-exercise Serum concentration of Interleukin-6 from venous blood sampling 48-hours after the exercise bout
Primary Change from baseline in Interleukin-6 concentration at 72-hours post-exercise Serum concentration of Interleukin-6 from venous blood sampling 72-hours after the exercise bout
Primary Change from baseline in Interleukin-6 concentration at 168-hours post-exercise Serum concentration of Interleukin-6 from venous blood sampling 168-hours after the exercise bout
Primary Muscle soreness (pressure algometry) at baseline Self-perceived rating of muscle soreness with use of pressure algometry Immediately pre-exercise
Primary Change in muscle soreness (pressure algometry) immediately post-exercise Self-perceived rating of muscle soreness with use of pressure algometry Immediately after the exercise bout
Primary Change in muscle soreness (pressure algometry) at 24-hours post-exercise Self-perceived rating of muscle soreness with use of pressure algometry 24-hours after the exercise bout
Primary Change in muscle soreness (pressure algometry) at 48-hours post-exercise Self-perceived rating of muscle soreness with use of pressure algometry 48-hours after the exercise bout
Primary Change in muscle soreness (pressure algometry) at 72-hours post-exercise Self-perceived rating of muscle soreness with use of pressure algometry 72-hours after the exercise bout
Primary Change in muscle soreness (pressure algometry) at 168-hours post-exercise Self-perceived rating of muscle soreness with use of pressure algometry 168-hours after the exercise bout
Primary Muscle soreness (visual analogue scale, VAS) at baseline Self-perceived rating of muscle soreness while performing a bodyweight squat with use of a visual analogue scale (0 - not sore at all, 10 - extremely sore) Immediately pre-exercise
Primary Change in muscle soreness (visual analogue scale, VAS) immediately post-exercise Self-perceived rating of muscle soreness while performing a bodyweight squat with use of a visual analogue scale (0 - not sore at all, 10 - extremely sore) Immediately after the exercise bout
Primary Change in muscle soreness (visual analogue scale, VAS) at 24-hours post-exercise Self-perceived rating of muscle soreness while performing a bodyweight squat with use of a visual analogue scale (0 - not sore at all, 10 - extremely sore) 24-hours after the exercise bout
Primary Change in muscle soreness (visual analogue scale, VAS) at 48-hours post-exercise Self-perceived rating of muscle soreness while performing a bodyweight squat with use of a visual analogue scale (0 - not sore at all, 10 - extremely sore) 48-hours after the exercise bout
Primary Change in muscle soreness (visual analogue scale, VAS) at 72-hours post-exercise Self-perceived rating of muscle soreness while performing a bodyweight squat with use of a visual analogue scale (0 - not sore at all, 10 - extremely sore) 72-hours after the exercise bout
Primary Change in muscle soreness (visual analogue scale, VAS) at 168-hours post-exercise Self-perceived rating of muscle soreness while performing a bodyweight squat with use of a visual analogue scale (0 - not sore at all, 10 - extremely sore) 168-hours after the exercise bout
Primary Range of motion at baseline Flexibility of the exercised limb as determined by goniometry Immediately pre-exercise
Primary Change in range of motion immediately post-exercise Flexibility of the exercised limb as determined by goniometry Immediately after the exercise bout
Primary Change in range of motion at 24-hours post-exercise Flexibility of the exercised limb as determined by goniometry 24-hours after the exercise bout
Primary Change in range of motion at 48-hours post-exercise Flexibility of the exercised limb as determined by goniometry 48-hours after the exercise bout
Primary Change in range of motion at 72-hours post-exercise Flexibility of the exercised limb as determined by goniometry 72-hours after the exercise bout
Primary Change in range of motion at 168-hours post-exercise Flexibility of the exercised limb as determined by goniometry 168-hours after the exercise bout
Primary Limb circumference at baseline Measure of leg circumference with use of standard anthropometric tape to indicate muscle swelling Immediately pre-exercise
Primary Change in limb circumference immediately post-exercise Measure of leg circumference with use of standard anthropometric tape to indicate muscle swelling Immediately after the exercise bout
Primary Change in limb circumference at 24-hours post-exercise Measure of leg circumference with use of standard anthropometric tape to indicate muscle swelling 24-hours after the exercise bout
Primary Change in limb circumference at 48-hours post-exercise Measure of leg circumference with use of standard anthropometric tape to indicate muscle swelling 48-hours after the exercise bout
Primary Change in limb circumference at 72-hours post-exercise Measure of leg circumference with use of standard anthropometric tape to indicate muscle swelling 72-hours after the exercise bout
Primary Change in limb circumference at 168-hours post-exercise Measure of leg circumference with use of standard anthropometric tape to indicate muscle swelling 168-hours after the exercise bout
See also
  Status Clinical Trial Phase
Completed NCT04136821 - The Long-term Effects of Oceanix™ on Resistance Training Adaptations N/A
Completed NCT03318731 - Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males N/A
Unknown status NCT02280668 - Investigating Muscle Repair in Response to Icing Therapy Post Eccentric Muscle Damage Exercise N/A
Recruiting NCT03766815 - Effect of Branched-chain Amino Acid Supplementation on Muscle Damage N/A
Completed NCT04315077 - The Short Term Effects of Oceanix Supplementation on Recovery N/A
Completed NCT03313388 - Tart Cherry Juice for Exercise Performance and Recovery N/A
Completed NCT03753321 - Whey and Soy Protein Supplementation in Football Players N/A
Recruiting NCT06334224 - Acute Physiological Responses to Twice Daily Blood Flow Restriction Training N/A
Recruiting NCT03707067 - Compression Garments for Recovery in Modern Pentathletes N/A
Completed NCT03707470 - Made to Measure Compression Garments for Recovery in Rugby Players N/A
Completed NCT05037942 - The Effects of Restriction Pressure on Muscle Damage Responses to Blood Flow Restriction Exercise N/A
Completed NCT05100459 - The Effects of Whey Protein Supplements on Markers of Exercise-induced Muscle Damage in Resistance-trained Individuals N/A
Recruiting NCT04549610 - HMB and Exercise-induced Muscle Damage Phase 2/Phase 3
Completed NCT05804604 - Bone Intake Proteins and Muscle Mass Deficiency in Proximal Femur Fractures
Completed NCT05011643 - Exercise-induced Muscle Damage in Statin Users
Completed NCT01827696 - Effect of American Ginseng on Exercise-induced Muscle Soreness Phase 1
Completed NCT01728675 - Eccentric Exercise and Oxidative Stress N/A
Completed NCT03527797 - Diaphragm Protective Ventilation in the Intensive Care Unit N/A
Withdrawn NCT05044936 - Topical Cannabidiol Cream and Post-exercise Recovery Early Phase 1
Completed NCT04679519 - The Effects of Protein Supplementation in Females and Males Following Acute Eccentric Exercise N/A